Concepedia

Ana Chauca-Diaz

AC

Statistics

Publications

4

Citations

374

H-Index

4

Active since

2017

Affiliations

University of Colorado Anschutz Medical Campus(Current)

University of Colorado Denver

Eastern Connecticut State University

Cedars-Sinai Medical Center

Colorado School of Public Health

Ana Chauca-Diaz is an author at University of Colorado Anschutz Medical Campus specializing in oncology, medicine, and molecular oncology.

Publications per year

2017–2021

4

Publications

4

Inhibition of the CCL2 receptor, CCR2, enhances tumor response to immune checkpoint therapy

Megan M. Tu, Hany Abdel-Hafiz, Robert T. Jones et al. · Communications Biology · 2020 · 172 citations · Full text

Life Sciences, Immunology, Oncology +17

Targeting DDR2 enhances tumor response to anti–PD-1 immunotherapy

Megan M. Tu, Francis Y. F. Lee, Robert T. Jones et al. · Science Advances · 2019 · 127 citations · Full text

Medicine, Immunology, Oncology +17

Androgen Receptor Regulates CD44 Expression in Bladder Cancer

Joseph L. Sottnik, Lauren A. Vanderlinden, Molishree Joshi et al. · Cancer Research · 2021 · 44 citations · Full text

Medicine, Molecular Biology, Oncology +15

Nuclear CD24 Drives Tumor Growth and Is Predictive of Poor Patient Prognosis

Jason E. Duex, Charles R. Owens, Ana Chauca-Diaz et al. · Cancer Research · 2017 · 31 citations · Full text

Medicine, Cell Biology, Oncology +15

1–4 of 4